News
-
-
-
COMMUNIQUÉ DE PRESSE
Oxurion completes the acquisition of Axiodis CRO and accelerates the structuring of its European clinical data platform
Oxurion completes the acquisition of 72% stake in Axiodis CRO, paving the way for an integrated platform focused on clinical data. Intensifies discussions with strategic targets in France and Europe -
COMMUNIQUÉ DE PRESSE
Oxurion rondt overname van Axiodis CRO af en versnelt uitbouw van haar Europese platform voor klinische data
Oxurion schliesst erfolgreich die Übernahme von 72% des Aktienkapitals von Axiodis CRO ab und beschleunigt die Gespräche mit strategischen Partnern zur Schaffung eines integrierten Plattforms für klinische Daten -
-
-
-
COMMUNIQUÉ DE PRESSE
Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV announces receipt of transparency notification on shareholder ownership crossing under threshold due to selling of voting securities. Press release replaces previous announcement -
-
